These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37212282)

  • 21. Intracranial Mesenchymal Chondrosarcoma Lacking the Typical Histopathological Features Diagnosed by
    Uneda A; Kurozumi K; Fujimura A; Kamiya A; Hirose T; Yanai H; Date I
    NMC Case Rep J; 2020 Apr; 7(2):47-52. PubMed ID: 32322450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mesenchymal chondrosarcoma with aberrant nuclear expression of STAT6: a potential diagnostic pitfall.
    Broggi G; Mazzucchelli M; Covello R; Casini B; Barbagallo GMV; Salvatorelli L; Magro G
    Pathol Res Pract; 2022 Apr; 232():153803. PubMed ID: 35217266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
    Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
    Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraparenchymal mesenchymal chondrosarcoma of the frontal lobe--a case report and molecular detection of specific gene fusions from archival FFPE sample.
    Sajjad EA; Sikora K; Paciejewski T; Garbicz F; Paskal W; Szacht M; Grajkowska W; Włodarski PK
    Clin Neuropathol; 2015; 34(5):288-93. PubMed ID: 25907264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary mesenchymal chondrosarcoma of the lung.
    Perry WR; McHugh JB; Konopka KE
    Pathol Int; 2023 Apr; 73(4):170-172. PubMed ID: 36752330
    [No Abstract]   [Full Text] [Related]  

  • 26. [Detection and analysis of HEY1-NCOA2 fusion gene in mesenchymal chondrosarcoma].
    Hao YH; Luo SY; Wang DZ; Tang XB
    Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):616-618. PubMed ID: 32486542
    [No Abstract]   [Full Text] [Related]  

  • 27. [Extraskeletal mesenchymal chondrosarcoma in central nerve system: a clinicopathological analysis].
    Wang YJ; Wang LM; Meng YH; Qi CH; Zhao LH; Lu DH; Teng LH
    Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1157-1162. PubMed ID: 34619870
    [No Abstract]   [Full Text] [Related]  

  • 28. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
    Syed M; Mushtaq S; Loya A; Hassan U
    Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mesenchymal chondrosarcoma in central nervous system: a clinicopathological analysis].
    Huang Q; Chen YP; Song FL; Zheng LM; Liu XY; Zhang S; Wang XF
    Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):870-875. PubMed ID: 34344069
    [No Abstract]   [Full Text] [Related]  

  • 30. Cell differentiation and matrix gene expression in mesenchymal chondrosarcomas.
    Aigner T; Loos S; Müller S; Sandell LJ; Unni KK; Kirchner T
    Am J Pathol; 2000 Apr; 156(4):1327-35. PubMed ID: 10751358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BAG3 promotes chondrosarcoma progression by upregulating the expression of β-catenin.
    Shi H; Chen W; Dong Y; Lu X; Zhang W; Wang L
    Mol Med Rep; 2018 Apr; 17(4):5754-5763. PubMed ID: 29484408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coordinated activation of notch, Wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity.
    Zamurovic N; Cappellen D; Rohner D; Susa M
    J Biol Chem; 2004 Sep; 279(36):37704-15. PubMed ID: 15178686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cartilage tumors: morphology, genetics, and current aspects of target therapy].
    Roessner A; Smolle M; Schoeder V; Haybaeck J
    Pathologe; 2020 Mar; 41(2):143-152. PubMed ID: 32060685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population.
    Ramanayake N; Vargas AC; Talbot J; Bonar F; Wong DD; Wong D; Mahar A; Karim R; Luk PP; Selinger C; Sioson L; Gill AJ; Maclean F
    Pathology; 2021 Oct; 53(6):705-712. PubMed ID: 33640159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors.
    Wehrli BM; Huang W; De Crombrugghe B; Ayala AG; Czerniak B
    Hum Pathol; 2003 Mar; 34(3):263-9. PubMed ID: 12673561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NKX3.1 immunoreactivity is not identified in mesenchymal chondrosarcoma: a 25-case cohort study.
    Chen W; Hornick JL; Fletcher CDM
    Histopathology; 2021 Jan; 78(2):334-337. PubMed ID: 32779239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary mesenchymal chondrosarcoma of the kidney without
    Yamagishi A; Ichiyanagi O; Naito S; Ito H; Kabasawa T; Yamakawa M; Tsuchiya N
    Oncol Lett; 2020 Jan; 19(1):885-891. PubMed ID: 31897203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma.
    Nyquist KB; Panagopoulos I; Thorsen J; Haugom L; Gorunova L; Bjerkehagen B; Fosså A; Guriby M; Nome T; Lothe RA; Skotheim RI; Heim S; Micci F
    PLoS One; 2012; 7(11):e49705. PubMed ID: 23185413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RUNX2 expression in developing human bones and various bone tumors.
    Sugawara M; Kato N; Tsuchiya T; Motoyama T
    Pathol Int; 2011 Oct; 61(10):565-71. PubMed ID: 21951664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant Cartilage-Forming Tumors.
    Hameed M
    Surg Pathol Clin; 2021 Dec; 14(4):605-617. PubMed ID: 34742483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.